Chapter 14 Review Questions Flashcards

1
Q

Afterloading techniques were developed primarily to reduce:

A

exposure to personnel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following statements about radioactivity is true?

a. The change in the number of atoms per unit time is proportional to the number of atoms present.
b. The change in unit time per change in the number of atoms is proportional to the number of atoms present.
c. The change in the number of atoms per unit time is equal to the number of disintegrations per second.
d. The change per unit time per change in the number of atoms is proportional to the number of disintegrations per second.

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The decay constant describes:

a. the half-life of a particular radionuclide.
b. the number of ionizations produced in tissue per unit time.
c. the fraction of the number of atoms that decay per unit time.
d. none of the above.

A

the fraction of the number of atoms that decay per unit time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the average lifetime of radioactive atoms is the definition of:

a. half-life.
b. decay constant.
c. specific activity.
d. mean life.

A

mean life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The dose profile (depth dose curve) around a brachytherapy source depends on the source’s:

a. activity.
b. strength.
c. energy.
d. half-life

A

energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The most commonly used isotopes for permanent implants are:

a. I-125 and Pd-103
b. Au-198 and I-125
c. Cs-137 and Pd-103
d. Ra-226 and Ir-192

A

I-125 and Pd-103

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Packing in gynecologic implants serves which of the following purposes?
I. Spaces sources to even out dose distributions.
II. Aids in pushing dose-sensitive structures farther from the sources
III. Provides stability of applicator placement.

A

II and III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A source’s activity is:

a. inversely proportional to the particle energy.
b. inversely proportional to treatment time.
c. inversely proportional to dose rate.
d. inversely proportional to exposure rate.

A

inversely proportional to treatment time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

when is interstitial brachytherapy used

A

prostate and breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

when is intracavitary brachytherapy used

A

cervical cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when is intraluminal brachtherapy used

A

esophagus and bronchus cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

when is surface brachytherapy used

A

ocular tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Time period in which the activity decays to one half of the original value.

A

half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The quantity of radiation emitted from a source used to describe, used to describe the strength of a source.

A

activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

average lifetime for the decay of radioactive atoms

A

mean life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

radioactive sources are placed directly in the targeted tissue where they stay permanently. The radioactive sources decay which might take weeks or months.

A

permanent brachytherapy

17
Q

the sources are placed for a period of time then removed. This could be for several days at which time the patient is placed in isolation to prevent exposure to others. The brachytherapy procedures you will participate in will have the source in the patients for minutes rather than days before being removed.

A

temporary brachytherapy

18
Q

point A coordinates

A

2 cm superior to the top of the ovoids along the tandem

2 cm lateral to the plan of the applicator

19
Q

point B coordinates

A

2 cm superior to the top of the ovoids

5 cm lateral to the patient midline (parametrial nodes)